EVENTS PER QUARTER · HOVER FOR EMPLOYEE COUNTS
Gossamer Bio, Inc. has laid off approximately 50 employees, which constitutes half of its workforce, following disappointing results from a clinical trial that led to a significant drop in stock prices. The layoffs are part of a restructuring effort aimed at reducing costs and refocusing the company's strategic priorities. This decision comes in the wake of challenges faced in the biotech sector, particularly concerning the efficacy of their drug candidates. The company is now looking to streamline operations and improve its financial standing after the trial setbacks.
No one has shared a story from Gossamer Bio, Inc. yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →We'll email you the moment a new layoff is reported here.